1Lockhat FB, Emembolu JD, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intri-uterine administered pregestogen:a 3 year follow-up.Hum Reprod, 2005, 20(3): 789-793.
2Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic in women with endometriosis. Hum Reprod, 2005, 26(5):5-8.
3D'Hooghe TM, Kvama C, Debrock S, et al. Future directions in endometriosis research. Ann N Y Acad Sci, 2004, 1034:316-325.
4Mettler L. GnRH agonist and add back therapy-indications, results and problems in the treatment of genital endometriosis. Zentralbl Gynakol, 2003,125(7-8): 267-275.
6Starczewski A, Glabowski W, Laszczynaka M, et al. The effect of ovarian steroid deficiency on regeneration of oviductal mucosa following reconstructive surgery. Reprod Biol, 2003, 3(3): 197-214.
7Valle RF, Sciarra JJ. Endomeiriosis: treatment strategies. Ann N VAcad Sci, 2003, 997(3):229-239.
8Davis CJ, McMillan L. Pain in endometriosis: effectiveness of medical and surgical management. Curt Opin Obstet Gynecol, 2003, 15(6):507-512.
9Huber AV, Huber JC, Kolbus A, et al. Systemic hCG treatment in patients with endometriosis: a new perspective for a painful disease.Wien Klin Wochenschr, 2004, 30(2): 116-143.
10Meresman GF, Bilotas MA, Lombardi E,et al. Effect of GnRH analogues on apoptosis and release of interleukin-1 beta and vascular endothelial cell cultures from patients with endometriosis. Hum Reprod, 2003, 18(9): 1767-1771.
